Targeting epigenetic demethylases: development of covalent inhibitors and PROTACs (Proteolysis Targeting Chimeras).

Project Information

TEDCIP

Grant agreement ID: 744389

DOI 10.3030/744389

Project closed

EC signature date 10 February 2017

Start date 1 August 2017

End date 31 January 2020

Funded under

• EXCELLENT SCIENCE - Marie Skłodowska-Curie Actions

Total cost € 183 454,80

EU contribution € 183 454,80

Coordinated by

THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD
United Kingdom

Publications

Peer reviewed articles (2)

Design, Synthesis and Characterization of Covalent KDM5 Inhibitors

Author(s): Saleta Vazquez-Rodriguez, Miranda Wright, Catherine M. Rogers, Adam P. Cribbs, Srikannathasan Velupillai, Martin Philpott, Henry Lee, James E. Dunford, Kilian V. M. Huber, Matthew B. Robers, James D. Vasta, Marie-Laetitia Thezenas, Sarah Bonham, Benedikt Kessler, James Bennett, Oleg Fedorov, Florence Raynaud, Adam Donovan, Julian Blagg, Vassilios Bavetsias, Udo Oppermann, Chas Bountra, Akane Kawam
Published in: Angewandte Chemie International Edition, Issue 58/2, 2019, Page(s) 515-519, ISSN 1433-7851
Publisher: John Wiley & Sons Ltd.
DOI: 10.1002/anie.201810179

Epigenetic Drug Discovery. Edited by Wolfgang Sippl and Manfred Jung

Author(s): Saleta Vazquez‐Rodriguez
Published in: ChemMedChem, 2019, ISSN 1860-7179
Publisher: Wiley - V C H Verlag GmbbH & Co.
DOI: 10.1002/cmdc.201900615